11.26.24 -- Considerations For Potency Assurance Of CGT Products

With a growing labor shortage in the biotechnology industry, the necessity to do larger-scale sample preparation with fewer skilled hands is increasing, putting a strain on many laboratories.

How can pharma manufacturing adapt to be more agile, data-driven, and prepared for the future? The solution lies in digital transformation.

What is a manufacturing roadmap? When should it be developed and implemented? And how can it improve your cell therapy manufacturing processes?

See how billions of γδ T cells can be generated from peripheral blood mononuclear cells with two distinct activation methods – a chemically defined, non-animal origin, serum-free medium, in a motion platform.

Sterile connectors streamline cell and gene therapy processes while maintaining sterility. By withstanding extreme temperatures and cryoprotectants, they can ensure product viability during cryopreservation.

Establishing early and clear tech transfer strategies is a key component of a holistic approach to drug development. Learn about the role that capable fill-finish solutions play in this process.

Explore two studies showing that a properly-assembled vial containment system ensures good CCI performance with stoppers of a given elastomer, regardless of configuration, size, or vial style.

The following study results demonstrate InstiGRO reagents' ability to substantially improve the cloning phase of cell line development workflows when manufacturing protein biologics and viral vectors.

An innovative transfection system addresses common production challenges by offering higher AAV titers, improved percent-full AAV capsids, and a straightforward workflow for AAV production platforms.